Moleculin Biotech, Inc. (MBRX) has a market capitalization of $2.95M and trades at $2.44. The 52-week range is 1.79-28.6.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-28.42.
The stock has a beta of 1.67, operates in the Healthcare sector.
